Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | EVP & President, TR&DT | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,530 |
Reported balance
After 2026-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 11,180 · Balance 54,530 F1: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 20:41 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 11,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001563606-26-000003 · wk-form4_1783370499.xml · derivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TR&DT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,530 Underlying: Common Stock · 11,180 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units ("RSUs") pursuant to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan, as amended (the "Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date. F2 · derivative.expiration_date: All RSUs reported in this row were granted under the Plan and will vest in full on the second anniversary of the grant date, subject to the Reporting Person's continued service through such date. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 43,350 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · derivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,350 Underlying: Common Stock · 43,350 shares Expires not disclosed F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/11/2026. Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 8,487 | $9.61 | $81,560.07 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,387 Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 687 | $9.55 | $6,560.85 |
DisclosureSEC source: 0001563606-26-000001 · wk-form4_1773350251.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,874 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 26,310 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0000917520-25-000024 · wk-form4_1741897543.xml · derivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,310 Underlying: Non-Qualified Stock Option (right to buy) · 26,310 shares Expires 2033-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2025. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 12,425 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000024 · wk-form4_1741897543.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,561 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 907 | $23.95 | $21,722.65 |
DisclosureSEC source: 0000917520-25-000024 · wk-form4_1741897543.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,136 Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 472 | $23.95 | $11,304.40 |
DisclosureSEC source: 0000917520-25-000024 · wk-form4_1741897543.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,043 Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 20:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 592 | $22.61 | $13,385.12 |
DisclosureSEC source: 0000917520-25-000019 · wk-form4_1741724247.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,515 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,581 | $35.88 | $56,726.28 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,107 Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 443 | $35.88 | $15,894.84 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 5 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,688 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon- Qualified Stock Option (right to buy) · Derivative | 14,963 | $0.00 Strike: $36.22 | $0.00 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · derivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,963 Underlying: Common Stock · 14,963 shares Expires 2032-03-11 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 13,805 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,131 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 6,478 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,326 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,952 | $36.22 | $70,701.44 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,848 Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:29 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 458 | $36.22 | $16,588.76 |
DisclosureSEC source: 0000917520-24-000036 · wk-form4_1710361779.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Read SEC document |
| March 10, 2024 Filed Mar 12, 2024 21:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 635 | $36.73 | $23,323.55 |
DisclosureSEC source: 0000917520-24-000029 · wk-form4_1710278184.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,258 Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,736 | $0.00 Strike: $32.59 | $0.00 |
DisclosureSEC source: 0000917520-24-000023 · wk-form4_1709932936.xml · derivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,736 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the stock options vested on the first, second, third and fourth anniversary of the original grant date of March 14, 2016. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 8,348 | $36.59 | $305,491.72 |
DisclosureSEC source: 0000917520-24-000023 · wk-form4_1709932936.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,893 F1 · shares: Represents shares sold in connection with a broker-assisted "sell to cover" cashless exercise transaction to cover the exercise price and withholding taxes upon the exercise of stock options scheduled to expire. F2 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $36.57 to $36.65 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:22 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 8,736 | $32.59 | $284,662.56 |
DisclosureSEC source: 0000917520-24-000023 · wk-form4_1709932936.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:43 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,721 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-24-000004 · wk-form4_1708638166.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,505 F1 · shares: On February 20, 2024, the Compensation Committee certified that the Company met or exceeded the average three-year annual organic revenue growth rate target for the performance period under the March 12, 2021 performance stock award. Accordingly, shares will vest on March 12, 2024, the third anniversary of the grant date. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,010 | $52.61 | $53,136.10 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 8 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,784 Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 459 | $52.61 | $24,147.99 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,794 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 755 | $52.87 | $39,916.85 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,253 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 453 | $52.87 | $23,950.11 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 5 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,008 Read SEC document |
| March 12, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 429 | $52.87 | $22,681.23 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,461 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 799 | $52.87 | $42,243.13 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,890 Read SEC document |
| March 11, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 458 | $52.87 | $24,214.46 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,689 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,354 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · derivative · entry 9 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,354 Underlying: Common Stock · 10,354 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,147 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,566 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · derivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,566 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 1,566 | $55.21 | $86,463.09 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,920 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 1,566 | $26.87 | $42,070.59 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,920 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,037 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,258 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,191 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,080 | $65.11 | $70,318.80 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 9 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,812 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 811 | $65.11 | $52,804.21 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 8 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,892 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 297 | $65.11 | $19,337.67 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,703 Read SEC document |
| March 13, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 335 | $65.11 | $21,811.85 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,000 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 665 | $65.11 | $43,298.15 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 5 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,335 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 1,109 | $65.11 | $72,206.99 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Read SEC document |
| March 12, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 277 | $65.11 | $18,035.47 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,109 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 9,193 | $0.00 Strike: $65.11 | $0.00 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · derivative · entry 10 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,193 Underlying: Common Stock · 9,193 shares Expires 2030-03-11 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2022. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,386 Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:44 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018844 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,778 Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:35 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 6,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009293 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,509 F3 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:35 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009293 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,043 F2 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:35 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009293 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,107 F1 · shares: On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.